Vmn2r84 Inhibitors
Vmn2r84 inhibitors encompass a diverse array of chemical compounds with varying modes of action, all converging to reduce the activity of this protein. For instance, zinc sulfate and copper(II) sulfate function by binding to specific sites on Vmn2r84, potentially altering its conformation and interfering with ligand binding or receptor dimerization, thereby attenuating receptor signaling. Similarly, tetraethylammonium, which blocks ion channels, could indirectly diminish Vmn2r84 signaling if it is associated with or regulates an ion channel. Beta-adrenergic receptor antagonists like propranolol and alpha-adrenergic antagonist phenoxybenzamine may disrupt adrenergic signaling pathways that have cross-talk with Vmn2r84. Pertussis toxin, which modifies G-proteins to prevent their interaction with GPCRs, could also indirectly inhibit Vmn2r84 if it is a GPCR or regulated by G-protein signaling.
Further inhibitors of Vmn2r84 include calcium channel blockers such as diltiazem and verapamil; by reducing the levels of intracellular calcium, they could negatively impact the Vmn2r84 signaling if it relies on calcium. Chelerythrine's inhibition of protein kinase C (PKC) could prevent phosphorylation events that modulate Vmn2r84 activity, while U73122 inhibits phospholipase C (PLC), potentially blocking the generation of second messengers crucial for Vmn2r84 signaling. Y-27632's targeting of Rho-associated protein kinase (ROCK) might impede cytoskeletal-related signaling pathways that regulate Vmn2r84. Lastly, PD 98059's inhibition of mitogen-activated protein kinase kinase (MEK) presents a mechanism by which the MAPK/ERK pathway could be suppressed, leading to an indirect reduction in Vmn2r84 activity, provided the protein's activity is modulated through this pathway. Each compound operates through distinct biochemical mechanisms, yet they all contribute to the attenuation of Vmn2r84 signaling within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can act as allosteric inhibitors of certain receptor proteins. By binding to distinct sites on Vmn2r84, zinc ions could potentially induce a conformational change that results in reduced receptor activity or the prevention of ligand binding, leading to decreased activation. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Copper ions may bind to specific sites on proteins, including receptors like Vmn2r84, altering their conformation and function. This binding could prevent the proper interaction with endogenous ligands or disrupt receptor dimerization, consequently inhibiting downstream signaling. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
As a non-selective beta-adrenergic receptor antagonist, propranolol could interfere with adrenergic signaling pathways that might indirectly modulate the activity of Vmn2r84 through cross-talk between signaling cascades. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem is a calcium channel blocker that can inhibit the influx of calcium ions. If Vmn2r84 signaling is calcium-dependent, diltiazem could indirectly inhibit the functional activity of Vmn2r84 by reducing available intracellular calcium. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Similar to diltiazem, verapamil is a calcium channel blocker. By lowering intracellular calcium levels, verapamil could indirectly inhibit the activity of Vmn2r84 if its signaling is contingent on calcium. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin irreversibly modifies G-proteins, preventing their interaction with G-protein-coupled receptors (GPCRs). If Vmn2r84 is a GPCR or its function is modulated by G-protein signaling, pertussis toxin would indirectly decrease its functional activity. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
This compound is a potent inhibitor of protein kinase C (PKC). If Vmn2r84's function is regulated by PKC-mediated phosphorylation, chelerythrine could inhibit its activity by preventing such phosphorylation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
As an inhibitor of the Rho-associated protein kinase (ROCK), Y-27632 could inhibit signaling pathways that involve cytoskeletal rearrangements. If Vmn2r84's function is linked to such pathways, its activity would be indirectly inhibited. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a specific inhibitor of mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway. If Vmn2r84 is regulated through this pathway, its activity could be indirectly inhibited by PD 98059 preventing MEK activation. | ||||||